Group pelvic floor training before prostate surgery
The Effect of Group Preoperative Pelvic Floor Training on Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate: A Prospective Cohort Study
This study is testing if group pelvic floor training before prostate surgery can help men with benign prostatic hyperplasia avoid urinary incontinence after their operation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 50 Years to 90 Years |
| Sex | Male |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT05719220 on ClinicalTrials.gov |
What this trial studies
This study investigates whether group pelvic floor training (PFT) prior to Holmium laser enucleation of the prostate (HoLEP) can reduce the incidence of urinary incontinence following surgery. It aims to recruit 100 patients diagnosed with benign prostatic hyperplasia (BPH) and assess the effectiveness of this preoperative intervention over a follow-up period of one to three months. The study will also analyze various factors that may predict urinary incontinence outcomes. By utilizing a group-based approach, the study seeks to enhance motivation and social support among participants.
Who should consider this trial
Good fit: Ideal candidates are men aged 50-90 diagnosed with benign prostatic hyperplasia who are scheduled for HoLEP.
Not a fit: Patients with severe urinary incontinence due to neurological conditions or those unable to participate in the pelvic floor training protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of urinary incontinence after prostate surgery, improving patient quality of life.
How similar studies have performed: While the efficacy of group preoperative pelvic floor training has not been previously reported, similar interventions have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Consecutive patients with a diagnosis of BPH with a plan to undergo HoLEP. * Between the age of 50-90. * Ability to understand and provide informed consent. Exclusion Criteria: * Patients whom inability to carry out PFT protocol. * Patients unwilling or unable to complete follow up care. * Severe urinary incontinence due to a history of neurological diseases such as a cerebrovascular accident or spinal cord injuries. * Patients whom inability to read and understand the English language.
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Thomas Chi, M.D. — University of California, San Francisco
- Study coordinator: Victoria Hogue
- Email: victoria.hogue@ucsf.edu
- Phone: 415-302-7443
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.